HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes

By J. Girard, C. Moussion, R. Förster. Nature reviews. Immunology, 2012

704 citations recorded by the source corpus.

Subfields: Immunology, Nephrology, Oncology

View Paper: https://www.semanticscholar.org/paper/4e88095754c38e555f3d2966e2ff9e522bc8b6e6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. G. Bergers
2. D. Hanahan

In Oncology

1. D. Hanahan
2. S. Evans
3. D. Fisher
4. G. Bergers
5. R. Weinberg
6. Rakesh K. Jain

Citations in the corpus

• Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation (2017, background): “With regard to the underlyingmechanisms of HEV induction in tumors, what is currently known is that CD11c DCs appear to be essential for the maintenance of HEVs in lymphoid organs (39).”
• The Two Faces of IL-6 in the Tumor Microenvironment (2014, background): “HEV-like vessels can also be induced at sites of chronic inflammation and have been identified in human solid tumors where they correlate with increased T lymphocyte infiltration and better prognosis [69].”